Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508293 | SCV001714347 | uncertain significance | not provided | 2019-10-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001882555 | SCV002151868 | uncertain significance | 2-aminoadipic 2-oxoadipic aciduria | 2022-07-25 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with DHTKD1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1163327). This variant is present in population databases (no rsID available, gnomAD 0.007%). This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 140 of the DHTKD1 protein (p.Gln140His). |